Why the study?
Does torasemide improve clinical efficacy and quality of life compared to furosemide in primary care patients with chronic heart failure?
Population
237 primary care patients with chronic heart failure (NYHA II-IV), all on ACE inhibitors.
Comparison
Torasemide for 9 months vs Furosemide for 9 months
Design
RCT, Randomized, Unblinded
Follow-up
9 months
Authors
Loading...
Torasemide improves symptoms, tolerability, and daily function versus furosemide in chronic HF; supports first-line preference and extends evidence to patient-reported outcomes.
Does torasemide improve clinical efficacy and quality of life compared to furosemide in primary care patients with chronic heart failure?
Torasemide provides superior improvements in quality of life, tolerability, and functional status compared to furosemide in patients with chronic heart failure.
Müller et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: